It’s always such an honor to hear Dr. Antoni Ribas from UCLA Jonsson Comprehensive Cancer Center speak. In his recent keynote at the ACS Trailblazers in Cancer Summit, he shared how decades of research transformed metastatic melanoma from an untreatable disease into a curable one — thanks to science.

How do wildfires impact cancer-related health in LA? Join our free Wildfire & Cancer Webinar on Monday, 4/21 to hear from leading experts across oncology, public health and environmental science. Register now: bit.ly/42zb6By

UCLA scientists are headed to #AACR25 in Chicago! From early detection to new targeted therapies, take a look at the UCLA-led research featured at this year’s conference. bit.ly/4iisEaH

#AACR25: A topical BRAF inhibitor gel, developed by UCLA researchers, offers the first real solution for painful skin rashes caused by anti-EGFR cancer therapies. Study shows LUT014 significantly improves rash severity & quality of life. bit.ly/4iFvuH8

How does the brain build itself & how can this knowledge help fight brain cancer? A new Nature Neuroscience study from the Aparna Bhaduri creates “meta-atlases” of the brain, revealing gene programs active in both development and brain tumors like glioblastoma. bit.ly/4lS2sqr

May is Brain Cancer Awareness Month. Researchers UCLA Health are advancing powerful new strategies to understand and treat aggressive brain tumors like #glioblastoma, including personalized vaccines and reprogramming cancer cells. Learn more: bit.ly/4iKWMff

Using artificial intelligence during routine screening could flag spots of concern invisible to the naked eye. David Geffen School of Medicine at UCLA UCLA Health UCLA Jonsson Comprehensive Cancer Center newsroom.ucla.edu/releases/ai-ea…

Spent the morning at the LA CBS studio with Dr. Hannah Milch, who talked about her latest study on AI & interval breast cancer. #KCALNEWS The study: uclahealth.org/news/release/a…

A new study led by Amar Kishan & published in JAMA Oncology shows that post-surgery radiation for prostate cancer can be safely completed in just 5 sessions using SBRT instead of daily sessions for several weeks, with no added side effects. bit.ly/4mkokLq

Researchers at UCLA Jonsson Comprehensive Cancer Center looked at how using MRI-guided biopsies and focal therapy can help men with prostate cancer remain on active surveillance. David Geffen School of Medicine at UCLA UCLA Health newsroom.ucla.edu/releases/advan…

UCLA Health is using AI to solve old problems in new ways. Researchers from UCLA Jonsson Comprehensive Cancer Center are discovering how to use AI to improve early detection of breast cancer — and the initial results are promising. newsroom.ucla.edu/releases/ai-ea…

6 doctors on Biden’s cancer diagnosis, how it may have arisen and his treatment options (w/ Seema): latimes.com/politics/story…

Today at #ASCO25, Dr. Aaron Lisberg presents promising early results on DB-1310, a HER3-targeted antibody-drug conjugate for advanced solid tumors. Don't miss his talk at 2:45pm CST during the Oral Abstract Session of the Developmental Therapeutics Track. bit.ly/4kFwAE3

A new study led by Siavash Kurdistani has uncovered a surprising survival strategy in cells that may help explain how MYC-driven cancers survive and grow despite limited resources. Learn more about the findings: bit.ly/4ehBVzB

A new UCLA-led study published in JCI insight found that a common autoimmune drug may help reverse immunotherapy-induced diabetes, a rare but life-threatening side effect of cancer treatment. Read more about the findings: bit.ly/3Tv8qRd

Congratulations to Arjan Gower, MD, MS on receiving a National Comprehensive Cancer Network (NCCN) grant to lead a multi-institutional clinical trial testing zipalertinib, a promising targeted therapy for early-stage non-small cell lung cancer with rare EGFR mutations. Read more about the award: bit.ly/407X89l

Researchers at UCLA Jonsson Comprehensive Cancer Center and David Geffen School of Medicine at UCLA are working to launch a first-in-human clinical trial to test the approach. newsroom.ucla.edu/stories/autoim…

A new UCLA study may explain why some liver tumors return after heat-based treatment. Researchers found that a protein, Galectin-1, helps cancer cells survive and regrow. Blocking it could make therapy more effective and reduce recurrence. Read more: bit.ly/4lLvQhh

Growing up in Alaska, Dr. David Nathanson (NathansonLab) dreamed of being a bush pilot. A chance meeting on a fishing trip changed everything and led him to UCLA, where he's now pioneering new therapies for glioblastoma. Read more about his journey: bit.ly/4eQbEbM

Blood tests offer a convenient way to screen for colorectal cancer, but a new UCLA study in Gastroenterology led by Fola May, MD PhD & Timothy Zaki, MD found only 49% of patients got the critical follow-up colonoscopy within 6 months after an abnormal result. bit.ly/45qyJi7